Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.
Andersen BK, Sejr-Hansen M, Maillard L, Campo G, Råmunddal T, Stähli BE, Guiducci V, Serafino LD, Escaned J, Santos IA, López-Palop R, Landmesser U, Dieu RS, Mejía-Rentería H, Koltowski L, Žiubrytė G, Cetran L, Adjedj J, Abdelwahed YS, Liu T, Mogensen LJH, Eftekhari A, Westra J, Lenk K, Casella G, Belle EV, Biscaglia S, Olsen NT, Knaapen P, Kochman J, Santos RC, Scarsini R, Christiansen EH, Holm NR.
Andersen BK, et al. Among authors: maillard l.
Lancet. 2024 Nov 9;404(10465):1835-1846. doi: 10.1016/S0140-6736(24)02175-5. Epub 2024 Oct 30.
Lancet. 2024.
PMID: 39488224
Clinical Trial.